Literature DB >> 9392606

Cellular and humoral immune responses of hydatidosis patients to Echinococcus granulosus purified antigens.

A Kharebov1, J Nahmias, J El-On.   

Abstract

The cellular and humoral immune responses of 41 hydatidosis patients, 12 healthy uninfected individuals, and seven patients with other parasitic diseases were determined using serologic and lymphoproliferative assays (LPAs), respectively. Echinococcal antigens were obtained by gel filtration of crude hydatid cyst fluid (HCF) on a Sephadex G-200 column. The fractions contained either a mixture of antigens A plus B or antigen B alone that was further enriched by boiling. All the hydatidosis patients responded positively by LPA to either crude or purified echinococcal antigens: 95% of them responded to either crude HCF, or a mixture of antigens A plus B and 83% to antigen B alone. The degree of the response to crude HCF (mean stimulation index [SI] = 75.3) was higher than that of purified antigens (SI = 39.1 for a mixture of antigens A plus B and SI = 36.9 for antigen B alone). No positive LPA response was obtained with the control groups. Serologic examinations showed that 78% of cases were positive by immunoblot, 73% by indirect hemagglutination, and 46% by immunoelectrophoresis. No correlation between the degree of cellular and humoral responsiveness to both crude and purified echinococcal antigens was observed. Nine of the 41 patients examined who were serologically negative also developed a high lymphoproliferative (LP) response to either crude or purified echinococcal antigens. The LP response remained positive over a long period after successful treatment. No relationship was observed between the results of treatment and the LP response. The present study indicates that the LPA could be used as an additional tool for the diagnosis of hydatid disease, particularly in seronegative cases, although it is unsuitable for effective monitoring treatment/surgery.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9392606     DOI: 10.4269/ajtmh.1997.57.619

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  6 in total

Review 1.  Multidetector CT and MR imaging cardiac hydatidosis: case report and review of the literature.

Authors:  Yan Xing; Dilimulati Bawudong; Wen-Bin Zhang; Wen-Ya Liu; Cun-Xue Pan; Hao Wen; Chen-Wei Li
Journal:  Int J Cardiovasc Imaging       Date:  2011-10-20       Impact factor: 2.357

2.  Surgical treatment of an Echinococcus cyst of the interventricular septum complicated by septic endocarditis, complete atrioventricular block, and rupture into the Valsalva sinus.

Authors:  Kakha Beselia; Merab Nachkepia; Kakhaber Gigilashvili; Grigol Keshelava; Giorgi Janashia; Guram Imnadze
Journal:  Gen Thorac Cardiovasc Surg       Date:  2010-05-07

3.  Immunological diagnosis of human cystic echinococcosis: utility of discriminant analysis applied to the enzyme-linked immunoelectrotransfer blot.

Authors:  I Gadea; G Ayala; M T Diago; A Cuñat; J G de Lomas
Journal:  Clin Diagn Lab Immunol       Date:  1999-07

4.  Heart echinococcus cyst as an incidental finding: early detection might be life-saving.

Authors:  Grigorios Tsigkas; Konstantinos Chouchoulis; Efstratios Apostolakis; Christina Kalogeropoulou; Nikolaos Koutsogiannis; Dimitra Koumoundourou; Dimitrios Alexopoulos
Journal:  J Cardiothorac Surg       Date:  2010-12-08       Impact factor: 1.637

5.  Application and assessment of a dipstick assay in the diagnosis of hydatidosis and trichinosis.

Authors:  Maged M Al-Sherbiny; Abd-Al Magid M K Farrag; Mohamed H Fayad; Mohamed K Makled; Gihan M Tawfeek; Nehad M S Ali
Journal:  Parasitol Res       Date:  2004-04-22       Impact factor: 2.289

6.  A set of recombinant antigens from Echinococcus granulosus with potential for use in the immunodiagnosis of human cystic hydatid disease.

Authors:  V G Virginio; A Hernández; M B Rott; K M Monteiro; A F Zandonai; A Nieto; A Zaha; H B Ferreira
Journal:  Clin Exp Immunol       Date:  2003-05       Impact factor: 4.330

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.